Ubs Group Ag Novo Nordisk A S Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Novo Nordisk A S stock. As of the latest transaction made, Ubs Group Ag holds 4,518 shares of NVO stock, worth $389,722. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,518

Previous 914,199 99.51%

Holding current value

$389,722

Previous $130 Million 99.59%

% of portfolio

0.0%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $5.18 Million - $6.33 Million	43,525 Added 4.76%	957,724 $114 Million
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $18.2 Million - $21.8 Million	148,546 Added 19.4%	914,199 $130 Million
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $21.8 Million - $29 Million	213,486 Added 38.66%	765,653 $98.3 Million
Q4 2023 Feb 09, 2024	SELL	$87.78 - $105.45 $6.6 Million - $7.93 Million	-75,223 Reduced 11.99%	552,167 $57.1 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $35.1 Million - $77 Million	385,675 Added 159.56%	627,390 $57.1 Million
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $4.37 Million - $4.84 Million	-28,008 Reduced 10.38%	241,715 $39.1 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $2.96 Million - $3.56 Million	-22,371 Reduced 7.66%	269,723 $42.9 Million
Q4 2022 Feb 08, 2023	SELL	$102.55 - $135.33 $561,666 - $741,202	-5,477 Reduced 1.84%	292,094 $39.5 Million
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $4.18 Million - $5.13 Million	43,848 Added 17.28%	297,571 $29.6 Million
Q2 2022 Aug 10, 2022	SELL	$103.24 - $121.81 $6.69 Million - $7.89 Million	-64,811 Reduced 20.35%	253,723 $28.3 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $1.38 Million - $1.67 Million	-14,798 Reduced 4.44%	318,534 $35.4 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $460,991 - $562,920	4,808 Added 1.46%	333,332 $37.3 Million
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $995,480 - $1.26 Million	-11,792 Reduced 3.47%	328,524 $31.5 Million
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $7.27 Million - $9.1 Million	-107,418 Reduced 23.99%	340,316 $28.5 Million
Q1 2021 May 12, 2021	BUY	$67.06 - $75.82 $215,061 - $243,154	3,207 Added 0.72%	447,734 $30.2 Million
Q4 2020 Feb 11, 2021	SELL	$63.89 - $73.8 $1.26 Million - $1.46 Million	-19,755 Reduced 4.25%	444,527 $31 Million
Q3 2020 Nov 12, 2020	BUY	$63.69 - $70.22 $146,423 - $161,435	2,299 Added 0.5%	464,282 $32.2 Million
Q2 2020 Jul 31, 2020	BUY	$58.54 - $67.94 $2.14 Million - $2.48 Million	36,492 Added 8.58%	461,983 $30.3 Million
Q1 2020 May 01, 2020	SELL	$49.46 - $64.78 $703,370 - $921,236	-14,221 Reduced 3.23%	425,491 $25.6 Million
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $86,158 - $100,673	-1,728 Reduced 0.39%	439,712 $25.5 Million
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $11.5 Million - $12.9 Million	-240,938 Reduced 35.31%	441,440 $22.8 Million
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $6.04 Million - $6.77 Million	129,043 Added 23.32%	682,378 $34.8 Million
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $752,515 - $854,290	-16,232 Reduced 2.85%	553,335 $28.9 Million
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $1.49 Million - $1.7 Million	-35,890 Reduced 5.93%	569,567 $26.2 Million
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $1.95 Million - $2.14 Million	41,679 Added 7.39%	605,457 $28.5 Million
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $3.21 Million - $3.66 Million	-72,539 Reduced 11.4%	563,778 $26 Million
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $3.71 Million - $4.45 Million	-76,495 Reduced 10.73%	636,317 $31.3 Million
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $3.7 Million - $4.18 Million	77,790 Added 12.25%	712,812 $38.3 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $149,909 - $179,308	3,643 Added 0.58%	635,022 $30.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	63,927 Added 11.27%	631,379 $27.1 Million
Q1 2017 Nov 14, 2017	BUY	N/A	567,452	567,452 $19.5 Million

Others Institutions Holding NVO

# of Institutions

1,955

Shares Held

318M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $195B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account